Thank you for your donation! Your payment is being processed. Please do not refresh or navigate away from this page.

diaLogue

SELECT A SECTION

Kelly L. Close is the founder and Chair of the Board of The diaTribe Foundation. Since 2006, she has been the Editor-in-Chief of diaTribe, our free website focused on making people with diabetes healthier and happier and advocating for action. Since 2002, she has also run Close Concerns, a healthcare information firm exclusively focused on diabetes and obesity. Each year Kelly and her colleagues attend over 50 scientific, regulatory, and economic conferences around the world, focused on diabetes and obesity. Kelly's passion for diabetes comes from her extensive professional work as well as her personal experience as a type 1 patient for nearly 30 years.

diaLogue

August 01, 2019

Many people with diabetes rely on medications and devices for their entire lives. For people with high-deductible insurance plans, this means there is no reprieve from costly spending on insulin, glucose monitors, and other therapies and technologies just to survive. In these situations, patients use their own funds (often from a health savings account, where money saved for medical expenses...

July 10, 2019

On July 10th, 2019, the U.S. Department of Health and Human Services (HHS) and the Trump Administration announced their commitment to prioritizing medical care for people living with kidney disease. In response, The diaTribe Foundation sent a letter thanking HHS and calling on the Department to recognize and include diabetes as a critical risk factor of chronic kidney disease. We urge HHS to...

May 28, 2019

In May, the FDA announced an opportunity to submit feedback on what patients prefer in their medical devices to guide the agency’s regulatory decisions.

The agency has posted a ...

May 08, 2019

Early this year, Illinois Representative Bobby Rush introduced a bill to eliminate cost-sharing for insulin covered under Medicare Part D or Medicaid. The legislation, H.R. 366 – Insulin Access for All Act of 2019, proposes to get rid of deductibles, copayments, and coinsurance for insulin and any...

March 12, 2019

diaTribe Founder Kelly Close was recently part of an American Diabetes Association (ADA) panel on therapeutic inertia. According to the ADA, therapeutic inertia is “the failure to establish appropriate targets and escalate treatment to achieve treatment goals.” Said differently, therapeutic inertia is part of the reason why advances diabetes medicines, devices, and treatment strategies don’t...

How You Can Join Us

Sign Up For diaTribe Updates!

We will never sell your data and we promise to keep your details safe and secure. For more information see our privacy policy.